CELUW
Income statement / Annual
Last year (2024), Celularity Inc.'s total revenue was $54.22 M,
an increase of 138.11% from the previous year.
In 2024, Celularity Inc.'s net income was -$57.89 M.
See Celularity Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$54.22 M |
$22.77 M |
$17.98 M |
$21.34 M |
$14.28 M |
$21.15 M |
$17.55 M |
| Cost of Revenue |
$14.99 M
|
$16.02 M
|
$2.35 M
|
$3.53 M
|
$4.93 M
|
$6.32 M
|
$6.56 M
|
| Gross Profit |
$45.33 M
|
$6.76 M
|
-$1.69 M
|
$11.68 M
|
$9.35 M
|
$14.82 M
|
$11.00 M
|
| Gross Profit Ratio |
0.84
|
0.3
|
-0.09
|
0.55
|
0.65
|
0.7
|
0.63
|
| Research and Development Expenses |
$17.39 M
|
$30.47 M
|
$78.36 M
|
$81.73 M
|
$52.71 M
|
$0.00
|
$29.06 M
|
| General & Administrative Expenses |
$0.00
|
$50.53 M
|
$65.86 M
|
$71.09 M
|
$30.57 M
|
$564.34 K
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$44.00 K
|
$163.00 K
|
$252.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$58.64 M
|
$50.58 M
|
$66.02 M
|
$71.34 M
|
$31.34 M
|
$1.68 M
|
$1.10 K
|
| Other Expenses |
$7.66 M
|
$118.00 M
|
-$120.47 M
|
$0.00
|
$3.39 M
|
$0.00
|
-$31.60 M
|
| Operating Expenses |
$77.59 M
|
$199.04 M
|
$23.91 M
|
$159.69 M
|
$161.27 M
|
$0.00
|
$1.10 K
|
| Cost And Expenses |
$92.58 M
|
$215.06 M
|
$43.58 M
|
$130.39 M
|
$166.20 M
|
$0.00
|
$1.10 K
|
| Interest Income |
$331.00 K
|
$320.00 K
|
$365.00 K
|
$332.00 K
|
$370.00 K
|
$694.00 K
|
$628.00 K
|
| Interest Expense |
$6.26 M
|
$3.02 M
|
$0.00
|
$3.17 M
|
$2.35 M
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$7.92 M
|
$9.32 M
|
$9.38 M
|
$8.82 M
|
$8.17 M
|
$6.19 M
|
$4.79 M
|
| EBITDA |
-$43.71 M |
-$183.95 M |
$23.58 M |
-$88.11 M |
-$202.41 M |
-$1.68 M |
-$1.10 K |
| EBITDA Ratio |
-0.81
|
-8.08
|
1.31
|
-4.13
|
-14.18
|
-0.08
|
-0
|
| Operating Income Ratio |
-0.71
|
-8.44
|
-1.42
|
-5.11
|
-10.64
|
-0.03
|
-0
|
| Total Other Income/Expenses Net |
-$19.53 M
|
-$4.00 M
|
$39.81 M
|
$8.96 M
|
-$61.01 M
|
$7.11 M
|
$2.00
|
| Income Before Tax |
-$57.89 M
|
-$196.29 M
|
$14.21 M
|
-$100.10 M
|
-$212.93 M
|
$6.55 M
|
-$1.10 K
|
| Income Before Tax Ratio |
-1.07
|
-8.62
|
0.79
|
-4.69
|
-14.91
|
0.31
|
-0
|
| Income Tax Expense |
$0.00
|
$10.00 K
|
$13.00 K
|
$20.00 K
|
-$4.70 M
|
$668.23 K
|
$21.30 M
|
| Net Income |
-$57.89 M
|
-$196.30 M
|
$14.19 M
|
-$100.12 M
|
-$208.23 M
|
$5.88 M
|
-$1.10 K
|
| Net Income Ratio |
-1.07
|
-8.62
|
0.79
|
-4.69
|
-14.58
|
0.28
|
-0
|
| EPS |
-2.64 |
-11.02 |
1.01 |
-14.9 |
-22.67 |
2.46 |
0 |
| EPS Diluted |
-2.64 |
-11.02 |
0.95 |
-14.9 |
-17 |
2.46 |
0 |
| Weighted Average Shares Out |
$21.89 M
|
$17.81 M
|
$13.99 M
|
$12.45 M
|
$9.19 M
|
$8.02 M
|
$35.94 M
|
| Weighted Average Shares Out Diluted |
$21.89 M
|
$17.81 M
|
$14.98 M
|
$12.39 M
|
$9.19 M
|
$8.02 M
|
$35.94 M
|
| Link |
|
|
|
|
|
|
|
